ImmunityBio IBRX
NASDAQ IBRX
$6.13 -0.55 (-8.17%)
As of: Nov 12, 2026 · 2:10 PM EST

ImmunityBio (IBRX) Sales of Property, Plant and Equipment (2018 - 2019)

Updated

ImmunityBio (IBRX) reported Sales of Property, Plant and Equipment of $20.5 million for FY2021.

Analysis

ImmunityBio (IBRX) Sales of Property, Plant and Equipment (2018 - 2019) Analysis & Trends

  • Sales of Property, Plant and Equipment has a three-year compound annual growth rate of 267.8% (FY2018 to FY2021).
  • According to Business Quant data, Sales of Property, Plant and Equipment came in at $200,000 in FY2019 (-51.5%) and $412,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 ImmunityBio 7.17 Bn 5.86 Bn 47.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 200,000.00
Dec 31, 2018 392,000.00
API Access

ImmunityBio Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=IBRX&period=max&api_key=YOUR_API_KEY